Preoperative infection prevention devices market seen reaching $3.52 billion by 2030

The market for preoperative infection prevention and wound cleansing devices is projected to grow from $2.33 billion in 2025 to $3.52 billion by 2030, driven by more surgeries, stricter infection control and rising focus on patient safety. Asia-Pacific is expected to be the fastest-growing region as healthcare infrastructure expands and procedure volumes rise.

Why it matters: - Preoperative infection prevention and wound cleansing devices help reduce surgical site infections and other complications before surgery. - Growing use of these devices reflects wider pressure on hospitals and clinics to improve patient safety and infection control. - The market’s expected 8.6% CAGR through 2030 signals durable demand tied to surgical volume and hygiene standards.

What happened: - The Business Research Company published a report titled “Preoperative Infection Prevention And Wound Cleansing Devices Market Report 2026 – Market Size, Trends, And Forecast 2026-2035.” - The report said the market will rise from $2.33 billion in 2025 to $2.53 billion in 2026. - The report projects the market will reach $3.52 billion by 2030. - The forecast period growth rate is 8.6% CAGR. - The report said Asia-Pacific is expected to be the fastest-growing region during the forecast period. - The report covers Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, the Middle East and Africa.

The details: - Rising surgical procedures, hospital-acquired infection awareness, stricter infection control protocols, broader preoperative hygiene standards and more elective surgeries supported recent growth. - Greater emphasis on patient safety, higher investment in infection prevention technology, more outpatient surgeries, tighter regulatory focus on surgical hygiene and wider use of advanced wound care solutions are expected to support future growth. - The report highlighted broader use of antiseptic preoperative solutions, demand for advanced wound cleansing systems, stronger focus on preventing surgical site infections, more single-use infection control devices and standardized preoperative protocols as major trends. - The market includes devices and measures that remove contaminants such as bacteria and debris from wound sites before surgery. - These products are used to support faster healing and reduce complications during the preoperative phase. - The report added new features for 2026, including market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix graphics and tables, Excel-based forecasting dashboards, market hotspots infographics, key technology and future trend analysis, and updated graphics and tables. - The company offered a free sample of the report and a full report download through the sample request page and the full market report.

Between the lines: - The growth case is closely tied to more procedures, not just better products. - The emphasis on outpatient surgery and single-use devices suggests demand is shifting toward faster, more standardized infection-control workflows. - Asia-Pacific’s lead implies the strongest upside is likely to come from healthcare buildout and higher surgical capacity, not mature markets alone. - The June 2024 American Society of Plastic Surgeons data cited in the report showed liposuction remained the most popular plastic surgery in the US in 2023, with nearly 350,000 procedures, up 7% from 2022.

What's next: - The market is expected to keep expanding through 2030 as infection prevention becomes more embedded in routine surgical care. - Adoption should continue to track surgical volumes, regulatory pressure and investment in wound care technology. - The report points to more standardized preoperative protocols and advanced cleansing tools as likely drivers of product development and procurement.

The bottom line: - Preoperative infection prevention and wound cleansing devices are moving from a niche clinical tool to a growth market tied to global surgery demand and stricter infection control.